Search results
Showing: 10 of 2137
Estimates Report
Key findings
The comparison of expected uptake to the actual volume of medicines used in the NHS in England is available in the national level medicine groupings interactive dashboard.
You can find the dashboard on the online web platform.
The…
Assumed Daily Dose (ADD) methodology
Introduction
This section explains the use of Assumed Daily Doses (ADDs) for measuring medicine utilisation in the Innovation Scorecard. It discusses why ADDs are used, how they are used in calculations, and the principles applied to assign ADDs.…
Drug Tariff news - May Part VIIIB
May Part VIIIB has been updated to include basic prices which will apply to prescriptions from 1st May 2015
Part VIIIB May 2015
Background Quality Notes
Introduction
This section of the report aims to provide users with an evidence-based assessment of the quality of the publication outputs. The quality of the outputs is assessed based on the nine European Statistical System (ESS) quality dimensions…
Update from the UK Government
The UK Government is working towards introducing new law to establish the Infected Blood Compensation Scheme. This will not have any immediate impact on your support payments.
On 17 April 2024 the UK Government tabled an amendment to the Victims…
Drug Tariff news - May Part VIIIB
Drug Tariff Part VIIIB has been reformatted for ease of use. The data hasn't changed and prices are effective from 01 May 2015.
May Part VIIIB
Guide to the underlying data
Presentation of the data
As part of our commitment to open data, the NHSBSA publishes the underlying data of the Innovation Scorecard publication in a series of comma-separated variable (csv) files.
The data has been released in csv files as these…
How to avoid unidentified prescribing
Unidentified prescribing occurs when the costs from a prescription cannot be matched to a prescriber at that practice or organisation. If we cannot match a prescriber to a practice, we will attribute prescribing costs to the lead prescriber at that…
Drug Tariff news - April Part VIIIA reimbursement prices
The Department of Health has agreed that the April Drug Tariff Part VIIIA reimbursement price for the following item is:
Sodium cromoglicate 2% eye drops £5.20
and not as printed in the April edition of the Drug Tariff
Drug Tariff news - May Part VIIIA reimbursement prices
The Department of Health has agreed that the May Drug Tariff Part VIIIA reimbursement prices for the following items will be:
Baclofen 10mg tablets £7.20
Clonidine 25microgram tablets £9.00
Digoxin 125microgram tablets £4.99
Digoxin…